Eisai Co. Ltd.

PNK: ESAIY · Real-Time Price · USD
7.16
-0.05 (-0.69%)
At close: May 01, 2025, 3:59 PM
-0.69%
Bid 7.16
Market Cap 8.09B
Revenue (ttm) 733.85B
Net Income (ttm) 32.65B
EPS (ttm) 0.36
PE Ratio (ttm) 19.89
Forward PE n/a
Analyst n/a
Ask 7.16
Volume 52,066
Avg. Volume (20D) 205,434
Open 7.17
Previous Close 7.21
Day's Range 7.12 - 7.23
52-Week Range 5.94 - 11.68
Beta -0.16

About ESAIY

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. It offers Dayvigo, for the treatment of insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; Methycobal for the treatment of peripheral neuropathy; and Halaven, an anticancer agent for the ...

Sector Healthcare
IPO Date Feb 2, 2023
Employees 11,067
Stock Exchange PNK
Ticker Symbol ESAIY
Full Company Profile